A Comprehensive Look at Tardive Dyskinesia Management

CCO Neuroscience Podcast

English - October 28, 2022 20:30 - 22 minutes - 20.8 MB - ★★★★★ - 3 ratings
Courses Education Science Life Sciences movement disorders neuromuscular disorders mood disorders Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Pharmacologic Management Options for Patients With Tardive Dyskinesia

Next Episode: Symptom Management in Bipolar Depression: Realistic Expectations and Strategies for Improvement

In this podcast episode, Robert O. Cotes, MD, and Jonathan M. Meyer, MD, discuss tardive dyskinesia from identification to follow-up and ongoing management. They provide valuable insights on pharmacologic options to both consider and avoid to optimize outcomes in patients with tardive dyskinesia, including a focus on clinical strategies for use of VMAT2 inhibitors.

Presenters:

Robert O. Cotes, MD
Associate Professor
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, Georgia

Jonathan M. Meyer, MD
Voluntary Clinical Professor, Department of Psychiatry
University of California, San Diego
Psychopharmacology Consultant
Balboa Naval Medical Center First Episode Psychosis Program
State of Nevada Project ECHO First Episode Psychosis Program